View in EDS HTML Full Text PDF Full Text

Heparanase modulates the prognosis and development of BRAF V600E-mutant colorectal cancer by regulating AKT/p27Kip1/Cyclin E2 pathway.

Saved in:

Bibliographic Details
Title:	Heparanase modulates the prognosis and development of BRAF V600E-mutant colorectal cancer by regulating AKT/p27Kip1/Cyclin E2 pathway.
Authors:	Liu, Mengling¹ (AUTHOR), Xu, Xiaojing¹ (AUTHOR), Peng, Ke¹ (AUTHOR), Hou, Pengcong¹ (AUTHOR), Yuan, Yitao¹ (AUTHOR), Li, Suyao¹ (AUTHOR), Sun, Xun¹ (AUTHOR), Shi, Zhongyi² (AUTHOR), Zhang, Jiayu¹ (AUTHOR), Dong, Yu¹ (AUTHOR), Liu, Qing¹ (AUTHOR), Ai, Luoyan¹ (AUTHOR), Liang, Li¹ (AUTHOR), Gan, Lu¹ (AUTHOR), Huang, Qihong^3,4,5 (AUTHOR), Yu, Yiyi¹ (AUTHOR) yu.yiyi@zs-hospital.sh.cn, Liu, Tianshu^1,4,6 (AUTHOR) liu.tianshu@zs-hospital.sh.cn
Source:	Oncogenesis. 9/21/2022, Vol. 11 Issue 1, p1-11. 11p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Be the first to leave a comment!